Literature DB >> 27734836

Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Nijiro Nohata1, Yusuke Goto2, J Silvio Gutkind1,3.   

Abstract

The G-protein-coupled receptor (GPCR) family is the largest family of cell-surface receptors involved in signal transduction. Aberrant expression of GPCRs and G proteins are frequently associated with prevalent human diseases, including cancer. In fact, GPCRs represent the therapeutic targets of more than a quarter of the clinical drugs currently on the market. MiRNAs (miRNAs) are also aberrantly expressed in many human cancers, and they have significant roles in the initiation, development and metastasis of human malignancies. Recent studies have revealed that dysregulation of miRNAs and their target genes expression are associated with cancer progression. The emerging information suggests that miRNAs play an important role in the fine tuning of many signaling pathways, including GPCR signaling. We summarize our current knowledge of the individual functions of miRNAs regulated by GPCRs and GPCR signaling-associated molecules, and miRNAs that regulate the expression and activity of GPCRs, their endogenous ligands and their coupled heterotrimeric G proteins in human cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27734836     DOI: 10.1038/jhg.2016.124

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  174 in total

1.  RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.

Authors:  Magali Berthebaud; Christel Rivière; Peggy Jarrier; Adlen Foudi; Yanyan Zhang; Daniel Compagno; Anne Galy; William Vainchenker; Fawzia Louache
Journal:  Blood       Date:  2005-07-05       Impact factor: 22.113

2.  MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.

Authors:  Bjørn Helge Haug; Jørn R Henriksen; Jochen Buechner; Dirk Geerts; Ellen Tømte; Per Kogner; Tommy Martinsson; Trond Flægstad; Baldur Sveinbjørnsson; Christer Einvik
Journal:  Carcinogenesis       Date:  2011-05-13       Impact factor: 4.944

3.  Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains.

Authors:  D Young; G Waitches; C Birchmeier; O Fasano; M Wigler
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

4.  MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.

Authors:  Hua-Nan Luo; Zheng-Hui Wang; Ying Sheng; Qing Zhang; Jing Yan; Jin Hou; Kang Zhu; Ying Cheng; Ying-Long Xu; Xiang-Hong Zhang; Min Xu; Xiao-Yong Ren
Journal:  Med Oncol       Date:  2013-12-07       Impact factor: 3.064

Review 5.  Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy.

Authors:  D B Cornelio; R Roesler; G Schwartsmann
Journal:  Ann Oncol       Date:  2007-03-09       Impact factor: 32.976

6.  MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened.

Authors:  Qi Xue; Kai Sun; Hai-Jun Deng; Shang-Tong Lei; Jing-Qing Dong; Guo-Xin Li
Journal:  Jpn J Clin Oncol       Date:  2013-11-25       Impact factor: 3.019

7.  Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126.

Authors:  Ying Y Lu; Michael J Sweredoski; David Huss; Rusty Lansford; Sonja Hess; David A Tirrell
Journal:  ACS Chem Biol       Date:  2013-11-25       Impact factor: 5.100

8.  MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  RNA       Date:  2014-07-01       Impact factor: 4.942

9.  Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.

Authors:  An Zou; Diana Lambert; Henry Yeh; Ken Yasukawa; Fariba Behbod; Fang Fan; Nikki Cheng
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

10.  MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.

Authors:  Hanwen Zhang; Qiuyu Wang; Qian Zhao; Wen Di
Journal:  J Ovarian Res       Date:  2013-11-26       Impact factor: 4.234

View more
  7 in total

Review 1.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

Review 2.  GPCRomics: An Approach to Discover GPCR Drug Targets.

Authors:  Paul A Insel; Krishna Sriram; Matthew W Gorr; Shu Z Wiley; Alexander Michkov; Cristina Salmerón; Amy M Chinn
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

Review 3.  The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders.

Authors:  Codrin-Constantin Burlacu; Maria-Adriana Neag; Andrei-Otto Mitre; Alexandru-Constantin Sirbu; Andrei-Vlad Badulescu; Anca-Dana Buzoianu
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

4.  MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.

Authors:  Xin-Long Ma; Feng Shang; Wei Ni; Jin Zhu; Bin Luo; Yu-Qi Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-17       Impact factor: 4.553

5.  Post-transcriptional suppression of G protein-coupled receptor 15 (GPR15) by microRNA-1225 inhibits proliferation, migration, and invasion of human colorectal cancer cells.

Authors:  Yuehui Guo; Qingyun Zhu; Shiwei Chen; Yanxiang Li; Daiquan Fu; Delin Qiao; Caifang Ni
Journal:  3 Biotech       Date:  2021-02-23       Impact factor: 2.406

Review 6.  Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis.

Authors:  Liang Du; Zhifeng Ning; Hao Zhang; Fuxing Liu
Journal:  Chin J Cancer       Date:  2017-03-09

7.  Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours.

Authors:  Benjamin Poret; Laurence Desrues; Marc-André Bonin; Martin Pédard; Martine Dubois; Richard Leduc; Romain Modzelewski; Pierre Decazes; Fabrice Morin; Pierre Vera; Hélène Castel; Pierre Bohn; Pierrick Gandolfo
Journal:  Biomolecules       Date:  2020-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.